June 16, 202619 min
Philips' Shez Partovi on increasing AI adoption, clinicians' attitudes and the hybrid care model
AI, Philips, Healthtech, Future Health Index 2026
Episodes
564
Latest episode
Jun 2026
Language
EN
About the show
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
Listen to episodes
June 15, 202624 min
The Socio-Economic Case For Prevention, With Deloitte’s Elizabeth Hampson
Prevention has moved to the centre of UK health policy, with the NHS 10-year plan promising a decisive shift away from treatment. The financial case for getting there is less widely understood. In this episode of the Over the Counter Podcast, HBW Insight's David Ridley speaks to Liz Hampson, life sciences and health innovation advisory partner at Deloitte, about the firm's recent work on the socioeconomic value of prevention. Hampson explains why every pound invested in prevention returns an estimated £9.20, why early intervention pays off most, and how rising out-of-pocket spending risks creating a two-tier system. The conversation also covers the gender health gap in prevention, the underused role of community pharmacy, and Hampson's argument that health literacy is where consumer health companies can make the greatest difference.
June 15, 202634 min
Drug Fix: WuXi vs. the Pentagon, New Advertising Citations, And FDA Explores The Limits Of AI
Pink Sheet Editor-in-Chief Nielsen Hobbs, Senior Editor Sue Sutter, and Senior Reporter Maaisha Osman discuss the Pentagon's decision to list WuXi Apptec as a “Chinese military company” (0:58), FDA’s latest adverting enforcement letters (13:02), and the agency’s thoughts on the risks and benefits of relying on AI for regulatory activities (21:16). More on these topics from the Pink Sheet: Pentagon Chinese Company Designations Resurface Pharma Supply Chain Concerns https://insights.citeline.com/pink-sheet/compliance/distribution-supply-chain/pentagon-chinese-company-designations-resurface-pharma-supply-chain-concerns-BMG2DWJI4NDA3DD3SYHIWXLTZI/ US Legislation Targets US-China Dealmaking Amid Fears Of Ceding Biotech Leadership https://insights.citeline.com/pink-sheet/legislation/us-legislation-targets-us-china-dealmaking-amid-fears-of-ceding-biotech-leadership-54FLFUBN7RELHO6WC7RN5OINYY/ BIOSECURE Legal Lifeline Available For Pharma Companies Using WuXi AppTec … For Now https://insights.citeline.com/pink-sheet/compliance/distribution-supply-chain/biosecure-legal-lifeline-available-for-pharma-companies-using-wuxi-apptec-for-now-KAD42FTHIJAT3AWS6OJMJHFM4M/ Pentagon Cleared WuXi AppTec Once. Now It Is Being Sued for Changing Its Mind. https://insights.citeline.com/pink-sheet/compliance/manufacturing/pentagon-cleared-wuxi-apptec-once-now-it-is-being-sued-for-changing-its-mind-XVGIQA3LIFEBZAG6AS6EMENHF4/ Recent US FDA Ad/Promo Untitled Letters Citing More Email, Internet Issues, Less DTC TV Spots https://insights.citeline.com/pink-sheet/compliance/marketing-and-advertising/recent-us-fda-adpromo-untitled-letters-citing-more-email-internet-issues-less-dtc-tv-spots-X2QUB5LZBRCRLNPGOJZJQMEIWU/ Unapproved Uses Safe Harbor Codified In Revised US FDA Payor Communications Guidance https://insights.citeline.com/pink-sheet/market-access/government-payers/unapproved-uses-safe-harbor-codified-in-revised-us-fda-payor-communications-guidance-GFHTVUWW7NBH3P2MT6GZL5JLJ4/ US FDA Says AI Played Supporting, Summarizing Role In Fast BLA Review https://insights.citeline.com/pink-sheet/product-reviews/us-fda-says-ai-played-supporting-summarizing-role-in-fast-bla-review-EKFWWY5SGZFVPL6PVKJVHJOVBQ/ Acting CDER Director Warns AI Over-Reliance Will Trigger GMP Violations https://insights.citeline.com/pink-sheet/advanced-technologies/ai/acting-cder-director-warns-ai-over-reliance-will-trigger-gmp-violations-7UO5KN7SJJBBLPQT7SLT3SWCJI/
June 15, 20264 min
【3分で解説 #世界のファーマ】第29回【トランプ関税で注目】米国、医薬品不足のいま (Japanese-language podcast)
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら：「US Drug Shortages Ease But Discontinuations Surge, Asia Supply Chain Risks Run Deep（邦訳：米国の医薬品不足は緩和も撤退数は増加、アジア由来の深いサプライチェーンリスク）」URL: https://insights.citeline.com/scrip/focus-on-asia/india/us-drug-shortages-ease-but-discontinuations-surge-asia-supply-chain-risks-run-deep-QTQCO6KNOBG25HXMVNV5HX5NM4/「US Tariffs And Manufacturing Concentration: Double-Edged Sword?（邦訳：米国の関税政策と製造の集中は諸刃の剣か？）」URL: https://insights.citeline.com/scrip/focus-on-asia/india/us-tariffs-and-manufacturing-concentration-double-edged-sword-5HPZCB6UY5EWZMK7QGJLJHS7IE/アメリカ薬局方 最新のVML（脆弱性薬品リスト）はこちらhttps://www.usp.org/sites/default/files/usp/document/public-policy/vulnerable-medicines-list-2025.pdf※全文の閲覧には購読（有料）が必要です。世界の製薬ビジネスメディアScrip（スクリップ）とは？https://www.citeline.com/ja-jp/products-services/commercialization/scrip
June 15, 202618 min
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 15, 2026
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年6月12日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 礼来探索Zepbound在自身免疫性疾病中的应用；阿斯利康在心血管风险管理（CVRM）领域推行互联互通战略； 阿斯利康将口服GLP-1药物推进至III期；勃林格殷格翰凭借survodutide致力于实现高质量减重；以及葛兰素史克通过收购Nuvalent扩大其肿瘤学版图。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-LLJSGYAJJ5EO3J5JMQYNNNSCMU/
June 15, 202617 min
Scrip's Five Must-Know Things - Jun. 15, 2026
Audio roundup of selected biopharma industry content from Scrip over the business week ended June 12, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time–Lilly explores Zepbound in autoimmune disorders; AstraZeneca pursues interconnected strategy in CVRM; AstraZeneca moving oral GLP-1 into Phase III; Boehringer pursues quality weight loss with survodutide; and GSK scales oncology ambitions with Nuvalent buy. Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-LLJSGYAJJ5EO3J5JMQYNNNSCMU/
June 9, 20263 min
플랙쉽 파이오니어링, 한국서 장기적 파트너십, 바이오 생태계 성장 모색 (Korean-language podcast)
Flagship Pioneering의 안드레 안도니안 아시아태평양 의장과 이병건 한국 담당 특별고문은 Scrip과의 인터뷰에서 새로운 파트너십을 모색하고, 자사의 기업 설립 모델을 국내 바이오 생태계에 적용하는 등 한국 시장 진출 전략을 공유했습니다.(AI 기반 텍스트 음성 변환 및 음성 모방 도구의 도움을 받아 제작되었습니다) Story link: https://insights.citeline.com/scrip/leadership/interviews/flagship-eyes-long-term-partnerships-biopharma-ecosystem-growth-in-korea-3IPE7SDKWNBATHEO7C4J5RHOGI/
June 8, 202618 min
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 8, 2026
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年6月5日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: Revolution公司的daraxonrasib在ASCO大会上引发轰动；默克公司（Merck & Co.）阐述其肿瘤学愿景；美国立法者对中美交易感到不满；ADA大会上的肥胖症治疗新挑战；以及2025年大型制药公司CEO薪酬回升。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-UH6HET2LLNGUJBCSJ3UA2KLGCQ/
June 8, 202616 min
Scrip's Five Must-Know Things - June 1, 2026
Audio roundup of selected biopharma industry content from Scrip over the business week ended May 29, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time – can GLP-1s help in cancer; Novartis on its cardiovascular strategy; Lilly’s retatrutide looks promising in obesity; Lilly’s raises cell and gene therapy bet; and the business impact of China’s new data protections. Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-QIUHRJ2UTNCIXB4T2CVZPNXG24/
June 8, 202617 min
Scrip's Five Must-Know Things - June 8, 2026
Audio roundup of selected biopharma industry content from Scrip over the business week ended June 5, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time – Revolution’s daraxonrasib makes splash at ASCO; Merck & Co. lays out oncology vision; US legislators bristle over US-China deals; obesity challengers at ADA; and big pharma CEO pay rebounds in 2025. Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-UH6HET2LLNGUJBCSJ3UA2KLGCQ/
Is this your show?
Claim this listing to keep it up to date, reach guests who want to pitch you, and manage bookings with Guestify.
Claim this listing
